Growth factorsPub Date : 2019-12-01Epub Date: 2020-03-12DOI: 10.1080/08977194.2020.1737528
Seyed Reza Mirhafez, Mohamad Tajfard, Ahmadreza Zarifian, Ali Movahedi, Nazanin Amiri, Hamideh Ghazizadeh, Amir Avan, Gordon A Ferns, Majid Ghayour-Mobarhan
{"title":"Association between the serum concentrations of 12 cytokines and growth factors and metabolic syndrome in patients undergoing angiography.","authors":"Seyed Reza Mirhafez, Mohamad Tajfard, Ahmadreza Zarifian, Ali Movahedi, Nazanin Amiri, Hamideh Ghazizadeh, Amir Avan, Gordon A Ferns, Majid Ghayour-Mobarhan","doi":"10.1080/08977194.2020.1737528","DOIUrl":"https://doi.org/10.1080/08977194.2020.1737528","url":null,"abstract":"<p><p>We aimed to compare the concentrations of serum cytokines in patients undergoing coronary angiography and finding their possible associations with metabolic syndrome. Twelve serum cytokines and growth factors (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, MCP-1, IFN-γ, EGF, and VEGF) were measured by sandwich chemiluminescence assays, on the Evidence Investigator<sup>®</sup> system. There were significant differences regarding sex, height, weight, BMI, WC, HC, FPG, TG and HDL-C between those with and without MetS in patients undergoing angiography (<i>p</i> < .05). Serum concentrations of IL-6 and INF-γ were significantly higher in subjects with MetS, compared to those without MetS (<i>p</i> = .031 and <i>p</i> = .035, respectively). However, only serum IL-6 was associated with the presence of MetS (β = 1.215, CI = 1.047-1.409, <i>p</i> = .010). From several serum cytokines and growth factors assessed in patients, IL-6 was the only serum cytokine that was significantly different between those with and without MetS after correction for confounding factors.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 5-6","pages":"238-246"},"PeriodicalIF":1.8,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2020.1737528","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37727819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"IGF-1 regulate the expression of uncoupling protein 2 via FOXO1.","authors":"Yukiko Watamoto, Kumi Futawaka, Misa Hayashi, Midori Matsushita, Mana Mitsutani, Zilin Song, Rie Koyama, Yuki Fukuda, Ayaka Nushida, Syoko Nezu, Akiko Kuwahara, Kazusaburo Kataoka, Tetsuya Tagami, Kenji Moriyama","doi":"10.1080/08977194.2020.1739032","DOIUrl":"https://doi.org/10.1080/08977194.2020.1739032","url":null,"abstract":"<p><p>Mitochondria uncoupling protein2 (UCP2) expressed ubiquitously is a key molecule of energy metabolism. Insulin-like growth factor-1 (IGF-1) is a hormone, a target molecule of growth hormone (GH) signal pathway, which is also known as the drug \"mecasermin\" for clinical usages. IGF-1 is seemed to be closely related to metabolic diseases, such as adult GH deficiency. However, there has not been reports depicted possible relationship with each other. So, we sought to elucidate the mechanisms by which expression of UCP2 is regulated by IGF-1 via FOXO1. The findings suggested that three sequences in the consensus <i>UCP2</i> promoter play complementary functional roles in the functional expression of FOXO1. So, we found that FOXO1 is involved in IGF-1-mediated energy metabolism greater than that of direct action of GH via STAT5. Our findings suggested that IGF-1 was involved in energy metabolism by regulating the expression of UCP2 via the PI3K/Akt/FOXO1 pathway.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 5-6","pages":"247-256"},"PeriodicalIF":1.8,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2020.1739032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37724877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of single bout downhill running on the serum irisin concentrations in rats.","authors":"Masanobu Murao, Tetsuo Imano, Junichi Akiyama, Teruhiko Kawakami, Masaaki Nakajima","doi":"10.1080/08977194.2020.1742118","DOIUrl":"https://doi.org/10.1080/08977194.2020.1742118","url":null,"abstract":"<p><p>This study aimed to characterize the effect of different running modes on serum irisin concentrations in rats. A total of 18, 10-week-old rats were divided into three groups; control group, 16° uphill running group (concentric exercise; CON) and, -16° downhill running group (eccentric exercise; ECC). The running group's rats ran on the inclined treadmill at 16 m/min, for a total of 90 min. Blood was drawn from the rats, 48 h after running, after which the rats were anesthetized. The serum concentrations of irisin were measured using enzyme-linked immunosorbent assays. Vastus intermedius was collected for immunohistochemical analysis. After multiple comparisons, the ECC showed a significantly high serum irisin concentration (ECC: 28.42 ± 6.31 ng/ml, CON: 21.27 ± 3.03 ng/ml) and a larger irisin antibody reactive cross-sectional area in vastus intermedius compared to the CON (<i>p</i> < 0.05). This is the first study to reveal that single bout downhill running increases serum irisin concentrations in rats.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 5-6","pages":"257-262"},"PeriodicalIF":1.8,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2020.1742118","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37761526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-12-01Epub Date: 2019-12-26DOI: 10.1080/08977194.2019.1703702
Siavash Foroughi, Jeanne Tie, Peter Gibbs, Antony Wilks Burgess
{"title":"Epidermal growth factor receptor ligands: targets for optimizing treatment of metastatic colorectal cancer.","authors":"Siavash Foroughi, Jeanne Tie, Peter Gibbs, Antony Wilks Burgess","doi":"10.1080/08977194.2019.1703702","DOIUrl":"https://doi.org/10.1080/08977194.2019.1703702","url":null,"abstract":"<p><p>The discovery of epidermal growth factor (EGF) and its receptor (EGFR) revealed the connection between EGF-like ligands, signaling from the EGFR family members and cancer. Over the next fifty years, analysis of EGFR expression and mutation led to the use of monoclonal antibodies to target EGFR in the treatment of metastatic colorectal cancer (mCRC) and this treatment has improved outcomes for patients. The use of the <i>RAS</i> oncogene mutational status has helped to refine patient selection for EGFR antibody therapy, but an effective molecular predictor of likely responders is lacking. This review analyzes the potential utility of measuring the expression, levels and activation of EGF-like ligands and associated processes as prognostic or predictive markers for the identification of patient risk and more effective mCRC therapies.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 5-6","pages":"209-225"},"PeriodicalIF":1.8,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1703702","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37493593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-12-01Epub Date: 2020-03-10DOI: 10.1080/08977194.2020.1735382
Marzieh Zarin, Narges Karbalaei, Sara Keshtgar, Marzieh Nemati
{"title":"Platelet-rich plasma improves impaired glucose hemostasis, disrupted insulin secretion, and pancreatic oxidative stress in streptozotocin-induced diabetic rat.","authors":"Marzieh Zarin, Narges Karbalaei, Sara Keshtgar, Marzieh Nemati","doi":"10.1080/08977194.2020.1735382","DOIUrl":"https://doi.org/10.1080/08977194.2020.1735382","url":null,"abstract":"<p><p>Our study aimed to investigate the effects of platelet-rich plasma (PRP) on impaired glucose homeostasis, disrupted islet insulin secretion, and pancreatic oxidative status in streptozotocin (STZ)-diabetic rats. A total of 64 Sprague-Dawley male were randomized to four groups including controls, diabetes, control-PRP, and diabetes-PRP. The rats received the PRP (0.5 ml/kg, SC injection) twice weekly for 4 weeks. Plasma glucose and insulin levels, pancreatic oxidative stress markers and islet insulin secretion and content were measured. Compared with the control group, in the diabetic group, increased plasma glucose and malondialdehyde (MDA) levels and decreased plasma insulin level, islet insulin secretion, pancreatic <b>s</b>uperoxide dismutase (SOD), and catalase activities were observed. PRP treatment significantly reduced plasma glucose and MDA levels and enhanced plasma insulin, antioxidant enzyme activity, islet insulin secretion, and content in the diabetic rats. These findings showed that PRP can improve pancreatic islet insulin secretion, pancreatic oxidative stress and regulate plasma insulin and glucose levels in diabetic rats.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 5-6","pages":"226-237"},"PeriodicalIF":1.8,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2020.1735382","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37720480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-08-01Epub Date: 2019-09-18DOI: 10.1080/08977194.2019.1662418
V I Seledtsov, V V Malashchenko, M E Meniailo, N D Gazatova, G V Seledtsova
{"title":"Granulocyte colony-stimulating factor downregulates interferon-gamma receptor expression and stimulates interleukin-6 production in activated human macrophages.","authors":"V I Seledtsov, V V Malashchenko, M E Meniailo, N D Gazatova, G V Seledtsova","doi":"10.1080/08977194.2019.1662418","DOIUrl":"10.1080/08977194.2019.1662418","url":null,"abstract":"<p><p>We studied direct effects of human granulocyte colony-stimulating factor (G-CSF) on phenotypical properties of human macrophage cells <i>in vitro</i>. CD14<sup>+</sup> monocyte/macrophages (Mc/Mphs) were isolated from blood of healthy donors by positive magnetic separation. G-CSF (0.01-1.0 ng/mL), when added to Mc/Mphs along with lipopolysaccharide (LPS, 1.0 μg/mL), was able to noticeably reduce proportions of CD119 (interferon-γ receptor 1)-positive cells, with no stable effects on CD16 (FcγRIII)<sup>+</sup> and СD124 (IL-4 receptor subunit alpha)-positive cells. In addition, G-CSF markedly upregulated IL-6 production by LPS-activated Mph cells, without significantly affecting IL-1β, IL-10 and tumor necrosis factor-α (TNF-α) secretion. Our data suggests that G-CSF could restrain Mph polarization to pro-inflammatory (M1) phenotype, thus potentially supporting pro-regenerative Mph activity with implications for immunotherapeutic interventions.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 1","pages":"164-169"},"PeriodicalIF":1.8,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1662418","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45631475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-07-04DOI: 10.1080/08977194.2019.1662415
Alyssa Bottrell, Y. Meng, Abdo J. Najy, N. Hurst, Seongho Kim, C. Kim, Eun‐sook Kim, A. Moon, Eun Joo Kim, S. Y. Park, H. Kim
{"title":"An oncogenic activity of PDGF-C and its splice variant in human breast cancer","authors":"Alyssa Bottrell, Y. Meng, Abdo J. Najy, N. Hurst, Seongho Kim, C. Kim, Eun‐sook Kim, A. Moon, Eun Joo Kim, S. Y. Park, H. Kim","doi":"10.1080/08977194.2019.1662415","DOIUrl":"https://doi.org/10.1080/08977194.2019.1662415","url":null,"abstract":"Abstract Despite strong evidence for the involvement of PDGF signaling in breast cancer, little is known about the PDGF ligand responsible for PDGFR activation during breast cancer progression. Here, we found PDGF-C to be highly expressed in breast carcinoma cell lines. Immunohistochemical analysis of invasive breast cancer revealed an association between increased PDGF-C expression and lymph node metastases, Ki-67 proliferation index, and poor disease-free survival. We also identified a PDGF-C splice variant encoding truncated PDGF-C (t-PDGF-C) isoform lacking the signal peptide and the N-terminal CUB domain. While t-PDGF C homodimer is retained intracellularly, it can be secreted as a heterodimer with full-length PDGF-C (FL-PDGF-C). PDGF-C downregulation reduced anchorage-independent growth and matrigel invasion of MDA-MB-231 cells. Conversely, ectopic expression of t-PDGF-C enhanced phenotypic transformation and invasion in BT-549 cells expressing endogenous FL-PDGF-C. The present study provides new insights into the functional significance of PDGF-C and its splice variant in human breast cancer.","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 1","pages":"131 - 145"},"PeriodicalIF":1.8,"publicationDate":"2019-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1662415","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43550137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-07-04DOI: 10.1080/08977194.2019.1685988
A. Modi, Shailender Dwivedi, D. Roy, Manoj Khokhar, P. Purohit, Jeewan Ram Vishnoi, P. Pareek, Shailja Sharma, Praveen Sharma, S. Misra
{"title":"Growth differentiation factor 15 and its role in carcinogenesis: an update","authors":"A. Modi, Shailender Dwivedi, D. Roy, Manoj Khokhar, P. Purohit, Jeewan Ram Vishnoi, P. Pareek, Shailja Sharma, Praveen Sharma, S. Misra","doi":"10.1080/08977194.2019.1685988","DOIUrl":"https://doi.org/10.1080/08977194.2019.1685988","url":null,"abstract":"Abstract Growth differentiation factor-15 (GDF-15) is a novel cytokine secreted by a variety of cells like macrophages, adipocytes, normally expressed in high amounts by placenta. It is also highly expressed in multiple carcinomas like Colon, Breast, Pancreas, Liver, and Ovarian. Several reports on serum GDF-15 as a potential biomarker for diagnosis and prognosis of cancer are hampered by the lack of robust data, with large sample size and critical patient recruitment. However, experimental accounts on cancer tumors, cell lines, and animal models suggest GDF-15’s role in cancer progression via endothelial mesenchymal transition, angiogenesis, metastasis, drug resistance and even stemness of various cancers. GDF-15 could be the point of amalgamation for the various hallmarks of cancer and can prove a useful therapeutic target in cancer. The current review was conceptualized with a thought of critically appraising the existing information of GDF-15 in carcinogenesis.","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 1","pages":"190 - 207"},"PeriodicalIF":1.8,"publicationDate":"2019-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1685988","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42746161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-07-04DOI: 10.1080/08977194.2019.1652399
S. Moon, C. Lee, See-Hyoung Park, Myeong Jin Nam
{"title":"Effects of hepatocyte growth factor gene-transfected mesenchymal stem cells on dimethylnitrosamine-induced liver fibrosis in rats","authors":"S. Moon, C. Lee, See-Hyoung Park, Myeong Jin Nam","doi":"10.1080/08977194.2019.1652399","DOIUrl":"https://doi.org/10.1080/08977194.2019.1652399","url":null,"abstract":"Abstract Nowadays, transplantation of human mesenchymal stem cells (MSCs) has emerged as a potential cellular therapy for liver cirrhosis. Hepatocyte growth factor (HGF) plays an important role in the regeneration of the liver. The objective of the study was to investigate the therapeutic effect of HGF-transfected human umbilical cord blood-derived MSCs on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. HGF-transfected MSCs were transplanted into rats with DMN-induced liver fibrosis. H2O2-induced cytotoxicity, apoptosis and intracellular reactive oxygen species were reduced in HGF-transfected MSCs in HGF-transfected MSCs. Pro-apoptotic proteins, such as cleaved poly (ADP-ribose) polymerase and cleaved caspase-3, were decreased in HGF-transfected MSCs. Biochemical analysis showed that the levels of aspartate aminotransferase and alanine aminotransferase were decreased after transplantation of HGF-transfected MSCs in rat fibrosis. Trichrome staining showed that HGF-transfected MSCs reduced liver damage. Taken together, our study indicated that HGF-transfected MSCs have therapeutic effects on DMN-induced liver fibrosis in rats.","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 1","pages":"105 - 119"},"PeriodicalIF":1.8,"publicationDate":"2019-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1652399","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42649356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2019-07-04DOI: 10.1080/08977194.2019.1662417
A. Ibrahim
{"title":"Association of growth performance and body conformational traits with BMP4 gene variation in Barki lambs","authors":"A. Ibrahim","doi":"10.1080/08977194.2019.1662417","DOIUrl":"https://doi.org/10.1080/08977194.2019.1662417","url":null,"abstract":"Abstract The objective of this study was to test the association of the variation in a 360 bp region in exon 2 of the ovine bone morphogenetic protein 4 (BMP4) gene with growth performance (birth weight, pre-weaning average daily gain, weaning weight, post-weaning average daily gain and marketing weight) and body conformational traits (height at withers, height at hips, body length, heart girth, thigh circumference, body mass index, skeletal muscle index, body index and relative body index) in 242 Barki lambs using polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP). Two variants (A and B) and three genotypes (AA, AB and BB) were detected. The BMP4 genotype significantly affected (p < .05 or p < .01) post-weaning daily gain, marketing weight, height at hips, thigh circumference, body mass index and skeletal muscle index. The results provided valuable information indicating selection for the BMP4 genotype might increase growth and muscularity in Barki lambs.","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":"37 1","pages":"153 - 163"},"PeriodicalIF":1.8,"publicationDate":"2019-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08977194.2019.1662417","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46859597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}